Influenza Hemagglutinin (HA) Peptide: Precision Tag for Protein Purification and Detection

Executive Summary:
The Influenza Hemagglutinin (HA) Peptide, with sequence YPYDVPDYA, is a nine-amino acid epitope tag derived from influenza virus hemagglutinin protein, facilitating reliable detection and purification of HA-tagged fusion proteins (APExBIO product page). It exhibits high solubility: ≥55.1 mg/mL in DMSO, ≥100.4 mg/mL in ethanol, and ≥46.2 mg/mL in water. HA Peptide enables competitive binding to anti-HA antibodies, allowing efficient elution of tagged proteins in immunoprecipitation workflows (Wei et al. 2021). Purity >98% is confirmed by HPLC and MS. HA tags are fundamental in molecular biology, supporting reproducible protein-protein interaction studies and exosome research (internal article).

Biological Rationale

The HA tag peptide, sequence YPYDVPDYA, originates from the human influenza hemagglutinin protein. It is used extensively as an epitope tag in recombinant protein technology (APExBIO). The tag is recognized with high specificity by monoclonal anti-HA antibodies (e.g., clone 12CA5). Its small size (9 residues) minimizes the risk of interfering with protein folding or function (related article). The HA tag is inert in most cellular contexts and is not found in common mammalian proteins, reducing background detection. This ensures suitability for sensitive protein detection and purification workflows in diverse expression systems.

Mechanism of Action of Influenza Hemagglutinin (HA) Peptide

The HA peptide tag functions by mimicking the epitope recognized by anti-HA antibodies. When fused to proteins of interest, it enables detection, affinity purification, and elution via immunoprecipitation. In elution protocols, excess synthetic HA peptide (such as the APExBIO A6004 product) competes for antibody binding, releasing the HA-tagged protein from the solid phase (Wei et al. 2021). High solubility in water (≥46.2 mg/mL), ethanol (≥100.4 mg/mL), and DMSO (≥55.1 mg/mL) enables versatility across lysis, wash, and elution buffers. The competitive binding mechanism is reversible and does not denature the target protein, preserving native conformation for downstream assays (internal Q&A article).

Evidence & Benchmarks

• HA-tagged proteins can be efficiently immunoprecipitated and specifically eluted using synthetic HA peptide at concentrations as low as 1 mg/mL in standard IP buffers (Wei et al. 2021, DOI).
• Purity of APExBIO HA Peptide (A6004) exceeds 98% by HPLC and mass spectrometry, minimizing risk of co-eluting contaminants (product data).
• High solubility (≥46.2 mg/mL in water) allows concentrated stock solutions to be prepared without precipitation, supporting reproducible immunoprecipitation and elution (internal protocol article).
• HA tag is compatible with both conventional and magnetic bead-based IP platforms, as validated in exosome biogenesis studies (Wei et al. 2021, DOI).
• Functional integrity of eluted proteins is maintained, enabling downstream analyses such as mass spectrometry or functional assays (internal methods article).

Applications, Limits & Misconceptions

The HA tag peptide is routinely used in the following applications:

• Detection of HA-tagged proteins by Western blot, ELISA, or immunofluorescence.
• Affinity purification of fusion proteins via anti-HA antibody columns or beads.
• Protein-protein interaction studies, including co-immunoprecipitation and exosome biogenesis research (Wei et al. 2021).
• Elution of HA-tagged proteins by competitive displacement with synthetic HA peptide, preserving protein structure (quantitative exosome workflow article).

The current article extends the discussion in this methods-focused review by benchmarking solubility, purity, and compatibility with magnetic and conventional IP platforms.

Common Pitfalls or Misconceptions

• HA tag does not confer functional activity; it is solely an epitope for antibody recognition.
• Not all anti-HA antibodies have the same affinity for the tag; optimal antibody selection is critical for maximal recovery.
• Excessive HA peptide in elution can sometimes interfere with downstream MS analysis if not adequately removed by buffer exchange (internal article).
• The HA tag sequence does not always guarantee solubility of the fusion protein itself.
• Long-term storage of peptide solutions can result in degradation; always store lyophilized at -20°C for stability (APExBIO).

Workflow Integration & Parameters

For immunoprecipitation or affinity purification, HA-tagged constructs are expressed in relevant cells. Lysates are incubated with anti-HA magnetic beads or antibody resin. Following washes, synthetic HA peptide (e.g., A6004) is added at 1–2 mg/mL in PBS or Tris buffer, pH 7.4, incubated at 4°C for 30–60 minutes. The eluted protein is collected by gentle centrifugation. APExBIO recommends preparing peptide stocks fresh before use and storing lyophilized material desiccated at -20°C. This Q&A article provides troubleshooting for optimizing yield and reproducibility, which this article updates with recent purity and solubility data.

Conclusion & Outlook

The Influenza Hemagglutinin (HA) Peptide (A6004, APExBIO) remains a validated, high-specificity tool for protein detection and purification. Its physical and chemical robustness, coupled with well-characterized antibody interactions, underpins reproducible workflows in molecular biology and exosome research. Ongoing advances in exosome biogenesis and protein interaction studies will continue to leverage the HA tag, with future work expected to refine quantitative and multiplexed applications (Wei et al. 2021). For detailed product specifications and ordering, visit the APExBIO Influenza Hemagglutinin (HA) Peptide product page.